Repurposing of Pentamidine as a Potential Inhibitor of the HMG-Box Protein in Toxoplasma gondii: An Integrated In Silico Approach
Background/Objectives: The identification of novel therapeutic targets is imperative to overcome the limitations of current anti-toxoplasmosis treatments. This study aims to investigate the potential of repurposing Pentamidine as an inhibitor against the HMG-Box domain-containing protein (TGARI_247020) in Toxoplasma go...